Company profile DAWN
After 39 days of this quarter the interest is at 83.0. Based on that we can calculate that during remaining 52 days it will total up to 194.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 68 inf% QoQ | 14 -79.4% QoQ | 66 371.4% QoQ |
| 2020 | 66 inf% YoY 0.0% QoQ | 24 -64.7% YoY -63.6% QoQ | 66 371.4% YoY 175.0% QoQ | 62 -6.1% YoY -6.1% QoQ |
| 2021 | 85 28.8% YoY 37.1% QoQ | 207 762.5% YoY 143.5% QoQ | 66 0.0% YoY -68.1% QoQ | 67 8.1% YoY 1.5% QoQ |
| 2022 | 116 36.5% YoY 73.1% QoQ | 276 33.3% YoY 137.9% QoQ | 106 60.6% YoY -61.6% QoQ | 153 128.4% YoY 44.3% QoQ |
| 2023 | 279 140.5% YoY 82.4% QoQ | 258 -6.5% YoY -7.5% QoQ | 140 32.1% YoY -45.7% QoQ | 177 15.7% YoY 26.4% QoQ |
| 2024 | 83 -70.3% YoY -53.1% QoQ | - | - | - |
The average 5 years interest of Day One Biopharmaceuticals was 9.11 per week. The last year interest of Day One Biopharmaceuticals compared to the last 5 years has changed by 80.24%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 421.27%.
There is not enough data for DAY101 clinical trial to provide analysis
There is not enough data for DAY101 clinical trial to provide correlation calculation
There is not enough data for DAY101 clinical trial to provide analysis
There is not enough data for Pediatric low-grade glioma treatment to provide analysis
There is not enough data for Pediatric low-grade glioma treatment to provide correlation calculation
There is not enough data for Pediatric low-grade glioma treatment to provide analysis
There is not enough data for Pimasertib clinical trials to provide analysis
There is not enough data for Pimasertib clinical trials to provide correlation calculation
There is not enough data for Pimasertib clinical trials to provide analysis
After 39 days of this quarter the interest is at 34.0. Based on that we can calculate that during remaining 52 days it will total up to 79.0. Day One Biopharmaceuticals stock expected interest is significantly higher compared to same quarter last year (+58.0%) but lower than previous quarter (-63.8%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 71 | 0 -100.0% QoQ | 0 -100.0% QoQ | 163 inf% QoQ |
| 2020 | 261 267.6% YoY 60.1% QoQ | 86 inf% YoY -67.0% QoQ | 110 inf% YoY 27.9% QoQ | 40 -75.5% YoY -63.6% QoQ |
| 2021 | 110 -57.9% YoY 175.0% QoQ | 208 141.9% YoY 89.1% QoQ | 65 -40.9% YoY -68.8% QoQ | 80 100.0% YoY 23.1% QoQ |
| 2022 | 162 47.3% YoY 102.5% QoQ | 183 -12.0% YoY 13.0% QoQ | 228 250.8% YoY 24.6% QoQ | 230 187.5% YoY 0.9% QoQ |
| 2023 | 50 -69.1% YoY -78.3% QoQ | 57 -68.9% YoY 14.0% QoQ | 172 -24.6% YoY 201.8% QoQ | 218 -5.2% YoY 26.7% QoQ |
| 2024 | 34 -32.0% YoY -84.4% QoQ | - | - | - |
The average 5 years interest of Day One Biopharmaceuticals stock was 9.69 per week. The last year interest of Day One Biopharmaceuticals stock compared to the last 5 years has changed by -4.54%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 29.37%.
There is not enough data for Day One Biopharmaceuticals careers to provide analysis
There is not enough data for Day One Biopharmaceuticals careers to provide correlation calculation
There is not enough data for Day One Biopharmaceuticals careers to provide analysis
After 39 days of this quarter the interest is at 113.0. Based on that we can calculate that during remaining 52 days it will total up to 264.0. Day One Biopharmaceuticals news expected interest is significantly higher compared to previous quarter (+613.5%) and same quarter last year (+956.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 29 | 19 -34.5% QoQ | 31 63.2% QoQ | 49 58.1% QoQ |
| 2020 | 74 155.2% YoY 51.0% QoQ | 44 131.6% YoY -40.5% QoQ | 26 -16.1% YoY -40.9% QoQ | 35 -28.6% YoY 34.6% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 52 18.2% YoY inf% QoQ | 0 -100.0% YoY -100.0% QoQ | 42 20.0% YoY inf% QoQ |
| 2022 | 12 inf% YoY -71.4% QoQ | 0 -100.0% YoY -100.0% QoQ | 25 inf% YoY inf% QoQ | 80 90.5% YoY 220.0% QoQ |
| 2023 | 25 108.3% YoY -68.8% QoQ | 37 inf% YoY 48.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 37 -53.8% YoY inf% QoQ |
| 2024 | 113 352.0% YoY 205.4% QoQ | - | - | - |
The average 5 years interest of Day One Biopharmaceuticals news was 2.8 per week. The last year interest of Day One Biopharmaceuticals news compared to the last 5 years has changed by 40.0%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 35.17%.
There is not enough data for Day One Biopharmaceuticals California to provide analysis
There is not enough data for Day One Biopharmaceuticals California to provide correlation calculation
There is not enough data for Day One Biopharmaceuticals California to provide analysis
After 39 days of this quarter the interest is at 75.0. Based on that we can calculate that during remaining 52 days it will total up to 175.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 10 | 42 320.0% QoQ | 48 14.3% QoQ | 33 -31.2% QoQ |
| 2020 | 24 140.0% YoY -27.3% QoQ | 92 119.0% YoY 283.3% QoQ | 65 35.4% YoY -29.3% QoQ | 14 -57.6% YoY -78.5% QoQ |
| 2021 | 77 220.8% YoY 450.0% QoQ | 119 29.3% YoY 54.5% QoQ | 50 -23.1% YoY -58.0% QoQ | 142 914.3% YoY 184.0% QoQ |
| 2022 | 86 11.7% YoY -39.4% QoQ | 228 91.6% YoY 165.1% QoQ | 139 178.0% YoY -39.0% QoQ | 140 -1.4% YoY 0.7% QoQ |
| 2023 | 275 219.8% YoY 96.4% QoQ | 225 -1.3% YoY -18.2% QoQ | 194 39.6% YoY -13.8% QoQ | 143 2.1% YoY -26.3% QoQ |
| 2024 | 75 -72.7% YoY -47.6% QoQ | - | - | - |
The average 5 years interest of Day One Biopharmaceuticals -company was 8.51 per week. The last year interest of Day One Biopharmaceuticals -company compared to the last 5 years has changed by 81.43%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 503.12%.
After 39 days of this quarter the interest is at 188.0. Based on that we can calculate that during remaining 52 days it will total up to 439.0. Targeted cancer therapies expected interest is significantly higher compared to same quarter last year (+46.3%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 162 | 309 90.7% QoQ | 337 9.1% QoQ | 176 -47.8% QoQ |
| 2020 | 126 -22.2% YoY -28.4% QoQ | 149 -51.8% YoY 18.3% QoQ | 262 -22.3% YoY 75.8% QoQ | 246 39.8% YoY -6.1% QoQ |
| 2021 | 354 181.0% YoY 43.9% QoQ | 278 86.6% YoY -21.5% QoQ | 166 -36.6% YoY -40.3% QoQ | 278 13.0% YoY 67.5% QoQ |
| 2022 | 249 -29.7% YoY -10.4% QoQ | 185 -33.5% YoY -25.7% QoQ | 268 61.4% YoY 44.9% QoQ | 81 -70.9% YoY -69.8% QoQ |
| 2023 | 300 20.5% YoY 270.4% QoQ | 360 94.6% YoY 20.0% QoQ | 414 54.5% YoY 15.0% QoQ | 347 328.4% YoY -16.2% QoQ |
| 2024 | 188 -37.3% YoY -45.8% QoQ | - | - | - |
The average 5 years interest of Targeted cancer therapies was 20.06 per week. The last year interest of Targeted cancer therapies compared to the last 5 years has changed by 41.97%. The interest for Targeted cancer therapies is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 44.06%.